Trading Signals: BCRX Stock Price Prediction and Forecast (Tue. Sep. 2, 2003 - Wed. Sep. 27, 2023)(BioCryst Pharmaceuticals, Inc.)
| BCRX latest price $14.5500 (-0.14%) ($14.4000 - $15.2600) on Mon. Dec. 5, 2005. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 6.98% (three month average) | RSI | 76 | Latest Price | $14.5500(-0.14%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | BCRX advances 3.5% a day on average for past five trading days. | Weekly Trend | BCRX advances 11.8% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support BCRX advance at 0% a week (0% probability) EEM(6%) IWM(6%) QQQ(6%) SPY(6%) VWO(6%) | Factors Impacting BCRX price | BCRX will decline at least -3.49% in a week (0% probabilities). SHY(-3%) REMX(-2%) TLT(-1%) TIP(-1%) LQD(-1%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -3.49% (StdDev 6.98%) | Hourly BBV | 0 () | Intraday Trend | 0.3% | | | |
|
5 Day Moving Average | $14.4(1.04%) | 10 Day Moving Average | $13.28(9.56%) | 20 Day Moving Average | $12.61(15.38%) | To recent high | -17.6% | To recent low | 75.7% | Market Cap | $2.567b | | | | BioCryst Pharmaceuticals, Inc. designs and develops novel, oral and small-molecule medicines. Its drug candidates include Berotralstat, BCX9930, BCX9250, RAPIVAB, ALPIVAB, RAPIACTA, PERAMIFLU, Galidesivir and Mundesine. The company was founded in 1986 and is headquartered in Durham, NC. |